A 52-year-old woman with major depressive disorder has been on tricyclic antidepressant (TCA) therapy for 3 months. She now presents with orthostatic hypotension, tachycardia, and urinary hesitancy. Which is the most common TCA-induced adverse effect responsible for her presentation?

Explanation

## Anticholinergic Effects of Tricyclic Antidepressants **Key Point:** Anticholinergic effects are the most common and clinically significant adverse effects of TCAs, occurring in 50–80% of patients. They result from blockade of muscarinic cholinergic receptors in the central and peripheral nervous systems. ### Mechanism of Anticholinergic Toxicity TCAs possess strong anticholinergic properties due to their tricyclic structure. Blockade of M1, M2, M3, and M4 muscarinic receptors leads to: 1. **Peripheral anticholinergic effects:** - Mydriasis (pupil dilation) - Cycloplegia (loss of accommodation) - Dry mouth and decreased salivation - Urinary hesitancy and retention - Constipation and ileus - Tachycardia 2. **Central anticholinergic effects:** - Confusion and delirium (especially in elderly) - Memory impairment - Hallucinations (in overdose) ### Cardiovascular Manifestations in This Case The patient's **orthostatic hypotension** and **tachycardia** are characteristic of TCA-induced anticholinergic effects: - **Orthostatic hypotension:** Results from α-adrenergic blockade (not anticholinergic, but co-occurs with anticholinergic effects in TCAs) - **Tachycardia:** Direct anticholinergic effect on the sinoatrial node (loss of vagal tone) - **Urinary hesitancy:** Classic anticholinergic effect on the detrusor muscle ### Comparative Anticholinergic Potency of TCAs | TCA | Anticholinergic Potency | Clinical Significance | |-----|-------------------------|----------------------| | **Amitriptyline** | **Very High** | Most problematic; avoid in elderly | | **Imipramine** | High | Moderate anticholinergic burden | | **Nortriptyline** | Moderate | Better tolerated than amitriptyline | | **Doxepin** | Moderate-High | Sedating; anticholinergic effects present | **High-Yield:** Amitriptyline and imipramine are the most anticholinergic TCAs; nortriptyline is relatively less anticholinergic and preferred in elderly patients. ### Management of Anticholinergic Adverse Effects 1. **Dose reduction** — may improve tolerability 2. **Switching to less anticholinergic agent** — e.g., nortriptyline or SSRIs 3. **Symptomatic treatment:** - Urinary retention: bethanechol (muscarinic agonist) - Constipation: stool softeners, increased fiber, osmotic laxatives - Dry mouth: artificial saliva, sugar-free gum 4. **Monitoring:** Regular assessment for anticholinergic toxicity, especially in elderly and polypharmacy patients **Clinical Pearl:** Anticholinergic effects are dose-dependent and often improve with time (tolerance develops), but may persist in some patients. In the elderly, anticholinergic burden from TCAs significantly increases risk of cognitive decline and falls. **Warning:** Do NOT use TCAs in patients with narrow-angle glaucoma, urinary retention, or severe constipation due to risk of acute angle closure and bowel obstruction.